PCPC3 has noted the revised, draft guidance on prostate cancer screening issued earlier this morning by the US Preventive Task Force. The full details of this new draft guidance can be found here.
PCPC3 is pleased to announce that its entire membership has reviewed and is highly supportive of the most recent version of the National Comprehensive Cancer Network’s (NCCN’s) new guidelines for patients on the diagnosis and treatment of prostate cancer.Read More »
September is Prostate Cancer Awareness Month and many of the leading patient advocacy organizations coordinate key activities for patients and prostate cancer advocates during this month.Read More »
PCPC3 — the patient-centered prostate cancer collaborative coalition — was initially conceived and discussed by a group of patient education and advocacy organizations attending the annual meeting of the American Urological Association in New Orleans on May 17, 2015.Read More »